LivaNova LIVN Neuromodulation — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LivaNova's neuromodulation — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LivaNova's neuromodulation — capex?
- LivaNova (LIVN) reported neuromodulation — capex of $8.84M in Q1 2026.
- How has LivaNova's neuromodulation — capex changed year-over-year?
- LivaNova's neuromodulation — capex increased by 335.0% year-over-year, from $2.03M to $8.84M.
- What is the long-term trend for LivaNova's neuromodulation — capex?
- Over 4 years (2021 to 2025), LivaNova's neuromodulation — capex has grown at a 206.7% compound annual growth rate (CAGR), from $179K to $15.83M.
- What does neuromodulation — capex mean?
- Funds used by the Neuromodulation segment to acquire, upgrade, or maintain physical assets such as manufacturing equipment or laboratory facilities. It indicates the level of investment in infrastructure to sustain or expand production capacity.